Jörn Dietrich

1.6k total citations
33 papers, 1.1k citations indexed

About

Jörn Dietrich is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jörn Dietrich has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Immunology. Recurrent topics in Jörn Dietrich's work include Epigenetics and DNA Methylation (19 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Immunotherapy and Immune Responses (6 papers). Jörn Dietrich is often cited by papers focused on Epigenetics and DNA Methylation (19 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Immunotherapy and Immune Responses (6 papers). Jörn Dietrich collaborates with scholars based in Germany, United States and Australia. Jörn Dietrich's co-authors include Dimo Dietrich, Glen Kristiansen, Heidrun Gevensleben, Diane Goltz, Jennifer Landsberg, Friedrich Bootz, Jörg Ellinger, Lukas Chávez, Bernd Timmermann and Ralf Herwig and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Genome Research.

In The Last Decade

Jörn Dietrich

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörn Dietrich Germany 20 706 465 308 242 187 33 1.1k
Hyung‐Gyoon Kim United States 17 541 0.8× 405 0.9× 197 0.6× 189 0.8× 134 0.7× 33 1.0k
Bernhard Reis Switzerland 13 512 0.7× 511 1.1× 507 1.6× 284 1.2× 296 1.6× 25 1.2k
Wen-Hsuan Yu Taiwan 6 801 1.1× 1.0k 2.2× 283 0.9× 446 1.8× 191 1.0× 8 1.5k
Zemin Zhang China 12 559 0.8× 612 1.3× 627 2.0× 298 1.2× 203 1.1× 23 1.3k
Guangcun Cheng China 8 380 0.5× 561 1.2× 340 1.1× 183 0.8× 98 0.5× 10 948
Lidia Moserle Italy 18 647 0.9× 496 1.1× 173 0.6× 341 1.4× 111 0.6× 26 1.1k
An Coosemans Belgium 21 409 0.6× 523 1.1× 545 1.8× 238 1.0× 283 1.5× 76 1.6k
Takaaki Yasuhara Japan 12 713 1.0× 663 1.4× 311 1.0× 128 0.5× 171 0.9× 22 1.2k
Mei‐Kuang Chen United States 12 527 0.7× 912 2.0× 348 1.1× 131 0.5× 191 1.0× 24 1.2k
Frank P. Vendetti United States 11 843 1.2× 411 0.9× 195 0.6× 162 0.7× 120 0.6× 18 1.1k

Countries citing papers authored by Jörn Dietrich

Since Specialization
Citations

This map shows the geographic impact of Jörn Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörn Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörn Dietrich more than expected).

Fields of papers citing papers by Jörn Dietrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörn Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörn Dietrich. The network helps show where Jörn Dietrich may publish in the future.

Co-authorship network of co-authors of Jörn Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of Jörn Dietrich. A scholar is included among the top collaborators of Jörn Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörn Dietrich. Jörn Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ralser, Damian J., Luka de Vos, Romina Zarbl, et al.. (2023). ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade. Biomarker Research. 11(1). 56–56. 4 indexed citations
2.
Vogt, Timo, Jörn Dietrich, Sebastian Strieth, & Dimo Dietrich. (2022). BTLA DNA methylation and mRNA expression in head and neck squamous cell carcinoma. Laryngo-Rhino-Otologie. 101(S 02). S200–S200. 1 indexed citations
5.
Dietrich, Jörn, Timo Vogt, Roland H. Stauber, et al.. (2020). The DNA Methylation Landscape of PD-1 ( PDCD1 ) and Adjacent LncRNA AC131097.3 in Head and Neck Squamous Cell Carcinoma. Epigenomics. 13(2). 113–127. 10 indexed citations
7.
Hoffmann, Friederike, Romina Zarbl, Dennis Niebel, et al.. (2020). Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clinical Epigenetics. 12(1). 94–94. 28 indexed citations
8.
Vos, Luka de, Maria Jung, Emma Bawden, et al.. (2020). Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood. Journal of Molecular Diagnostics. 22(7). 920–933. 22 indexed citations
9.
Gevensleben, Heidrun, Jörn Dietrich, Friedrich Bootz, et al.. (2018). PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations. EBioMedicine. 28. 97–104. 57 indexed citations
10.
Semaan, Alexander, Heidrun Gevensleben, Jörn Dietrich, et al.. (2018). Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study. British Journal of Cancer. 118(9). 1217–1228. 63 indexed citations
11.
Sailer, Verena, Emily Eva Holmes, Heidrun Gevensleben, et al.. (2017). PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma. Clinical Epigenetics. 9(1). 12–12. 14 indexed citations
12.
Goltz, Diane, Heidrun Gevensleben, Jörn Dietrich, et al.. (2016). PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia. Leukemia. 31(3). 738–743. 69 indexed citations
13.
Goltz, Diane, Emily Eva Holmes, Heidrun Gevensleben, et al.. (2016). CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients. Oncotarget. 7(33). 53309–53320. 26 indexed citations
14.
Goltz, Diane, Heidrun Gevensleben, Jörn Dietrich, & Dimo Dietrich. (2016). PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients. OncoImmunology. 6(1). e1257454–e1257454. 71 indexed citations
15.
Semaan, Alexander, Dimo Dietrich, Jörn Dietrich, et al.. (2016). CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(2). 185–196. 65 indexed citations
16.
Grimm, Christina, Lukas Chávez, Mireia Vilardell, et al.. (2013). DNA–Methylome Analysis of Mouse Intestinal Adenoma Identifies a Tumour-Specific Signature That Is Partly Conserved in Human Colon Cancer. PLoS Genetics. 9(2). e1003250–e1003250. 40 indexed citations
17.
Krestyaninova, Maria, Ola Spjuth, Janna Hastings, Jörn Dietrich, & Dietrich Rebholz‐Schuhmann. (2012). Biobank Metaportal to Enhance Collaborative Research: sail.simbioms.org. SHILAP Revista de lepidopterología. 3 indexed citations
18.
Dietrich, Dimo, Manuel Krispin, Jörn Dietrich, et al.. (2010). CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients. BMC Cancer. 10(1). 247–247. 40 indexed citations
19.
Chávez, Lukas, Justyna Józefczuk, Christina Grimm, et al.. (2010). Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Research. 20(10). 1441–1450. 132 indexed citations
20.
Dietrich, Dimo, Ralf Lesche, Reimo Tetzner, et al.. (2009). Analysis of DNA Methylation of Multiple Genes in Microdissected Cells From Formalin-fixed and Paraffin-embedded Tissues. Journal of Histochemistry & Cytochemistry. 57(5). 477–489. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026